Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0000899243-16-032929

Options or other derivatives

  • Chief Commercial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hurley Charles Andrew · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-11-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +100,000 $5.21 2026-11-06 100,000 100,000 D
Loading xslF345X03/doc4.xml…